Eli Lilly and Company (LLY)

Index:

S&P 100

$ 794.10
   
  • Change Today:
    $-104.85
  • 52 Week High: $960.02
  • 52 Week Low: $720.91
  • Currency: US Dollars
  • Shares Issued: 948.17m
  • Volume: 12,601,092
  • Market Cap: $752,942m
  • RiskGrade: 179
  • Beta: 0.76

Latest ShareCast News

Lilly shares jump on positive results from oral weight-loss drug trial

By Benjamin Chiou

Date: Thursday 17 Apr 2025

(Sharecast News) - Shares in Eli Lilly & Co were set to soar on Wednesday on the back of positive results of a late-stage trial of its weight-loss pill Orforglipron, which is thought to be a needle-free alternative to Novo Nordisk's popular injectable Ozempic drug.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

LLY Market Data

Currency US Dollars
Share Price $ 794.10
Change Today $ -104.85
% Change -11.66 %
52 Week High $960.02
52 Week Low $720.91
Volume 12,601,092
Shares Issued 948.17m
Market Cap $752,942m
Beta 0.76
RiskGrade 179

What The Brokers Say

Strong Buy 11
Buy 10
Neutral 5
Sell 0
Strong Sell 0
Total 26
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 01-May-2025

Time Volume / Share Price
15:59 200 @ $793.81
15:59 100 @ $794.09
15:59 100 @ $793.99
15:59 100 @ $793.92
15:59 100 @ $793.66

Top of Page